Glycogen Synthase Kinase 3β Inhibitor (2'Z,3'E)-6-Bromo-indirubin- 3'-Oxime Enhances Drug Resistance to 5-Fluorouracil Chemotherapy in Colon Cancer Cells.
about
Glycogen Synthase Kinase 3β Inhibitor (2'Z,3'E)-6-Bromo-indirubin- 3'-Oxime Enhances Drug Resistance to 5-Fluorouracil Chemotherapy in Colon Cancer Cells.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Glycogen Synthase Kinase 3β In ...... therapy in Colon Cancer Cells.
@ast
Glycogen Synthase Kinase 3β In ...... therapy in Colon Cancer Cells.
@en
Glycogen Synthase Kinase 3β In ...... therapy in Colon Cancer Cells.
@nl
type
label
Glycogen Synthase Kinase 3β In ...... therapy in Colon Cancer Cells.
@ast
Glycogen Synthase Kinase 3β In ...... therapy in Colon Cancer Cells.
@en
Glycogen Synthase Kinase 3β In ...... therapy in Colon Cancer Cells.
@nl
prefLabel
Glycogen Synthase Kinase 3β In ...... therapy in Colon Cancer Cells.
@ast
Glycogen Synthase Kinase 3β In ...... therapy in Colon Cancer Cells.
@en
Glycogen Synthase Kinase 3β In ...... therapy in Colon Cancer Cells.
@nl
P2093
P2860
P1476
Glycogen Synthase Kinase 3β In ...... therapy in Colon Cancer Cells.
@en
P2093
Kun-Ping Liu
Li-Juan Tang
Mei-Xiang Chen
Si-Ming Xie
Xue-Fang Wu
Xue-Yun Zhong
P2860
P2888
P304
P356
10.1007/S11670-012-0116-9
P577
2012-06-01T00:00:00Z